Palomar Medical Technologies, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Palomar Medical Technologies, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ted Molczan who wrote (475)	4/29/1997 8:05:00 PM
From: Ted Molczan	of 708

Palomar's response to MEHL/Biophile's press release came at about 4:30 PM: prnewswire.com The laser hair removal patent dispute remains unresolved, for now. I have read both the MGH patent and the Zaias patent, and found that they are quite different from one another, so I would not be surprised if neither one will prevail over the other, legally. The patent dispute is a mere sideshow to the main issue: efficacy. Thus far, FDA does not allow claims of long-term, let alone permanent results, so laser hair removal is temporary. Therefore, laser must show that it can successfully compete against waxing treatments, which cost 10 to 20 times less. That seems unlikely. Ted Molczan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next